• 1
  • 2
    Central Statistical Agency [Ethiopia] and ICF International. 2012. Ethiopia Demographic and Health Survey 2011; 2012.
  • 3
    Policy Planning Directorate. Health and Health Related Indicators 2010/2011; 2012.
  • 4
  • 5
    Jemal A, Bray F, Forman D, et al. Cancer burden in Africa and opportunities for prevention. Cancer 2012;118:437284.
  • 6
    McCormack VA, Boffetta P. Today's lifestyles, tomorrow's cancers: trends in lifestyle risk factors for cancer in low- and middle-income countries. Ann Oncol 2011;22:234957.
  • 7
    Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents, vol. 9. IARC Scientific Publications No. 160. Lyon, France: International Agency for Research on Cancer, 2007.
  • 8
    Kantelhardt EJ, Hanson C, Albert US, et al. Breast cancer in countries of limited resources. Breast Care 2008;3:127.
  • 9
  • 10
  • 11
    Love RR. Defining a global research agenda for breast cancer. Cancer 2008;113:236671.
  • 12
    Anderson BO, Cazap E, El Saghir NS, et al. Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010. Lancet Oncol 2011;12:38798.
  • 13
    Anderson BO, Shyyan R, Eniu A, et al. Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines. Breast J 2006;12 (Suppl 1):S3-S15.
  • 14
    Reeler AV, Sikora K, Solomon B. Overcoming challenges of cancer treatment programmes in developing countries: a sustainable breast cancer initiative in Ethiopia. Clin Oncol (R Coll Radiol) 2008;20:1918.
  • 15
    Jensen OM, Parkin DM, MacLennan R, et al. Cancer registration: principles and methods. IARC Scientific Publication No. 95. Lyon, France: WHO, 1991.
  • 16
    Edge SB. AJCC cancer staging manual, 7th edn. New York: Springer, 2010.
  • 17
    Sobin L, Gospodarowicz M, Wittekind C, eds. TNM classification of malignant tumors, 7th edn. Hoboken, NJ: Wiley, 2009.
  • 18
    Greenland S, Pearl J, Robins JM. Causal diagrams for epidemiologic research. Epidemiology 1999;10:3748.
  • 19
    Knuppel S, Stang A. DAG program: identifying minimal sufficient adjustment sets. Epidemiology 2010;21:159.
  • 20
    Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika 1982;69:23841.
  • 21
    Agboola AJ, Musa AA, Wanangwa N, et al. Molecular characteristics and prognostic features of breast cancer in Nigerian compared with UK women. Breast Cancer Res Treat 2012;135:55569.
  • 22
    Youlden DR, Cramb SM, Dunn NAM, et al. The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol 2012;36:23748.
  • 23
    Sankaranarayanan R, Swaminathan R, Brenner H, et al. Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol 2010;11:16573.
  • 24
    Gakwaya A, Kigula-Mugambe JB, Kavuma A, et al. Cancer of the breast: 5-year survival in a tertiary hospital in Uganda. Br J Cancer 2008;99:637.
  • 25
    Ersumo T. Breast cancer in an Ethiopian population, Addis Ababa. East Central Afr J Surg 2006;11:81-6.
  • 26
    Ly M, Antoine M, Dembele AK, et al. High incidence of triple-negative tumors in sub-Saharan Africa: a prospective study of breast cancer characteristics and risk factors in Malian women seen in a Bamako University Hospital. Oncology 2012;83:25763.
  • 27
    Rambau PF, Chalya PL, Manyama MM, et al. Pathological features of breast cancer seen in Northwestern Tanzania: a nine years retrospective study. BMC Res Notes 2011;4:214.
  • 28
    Ohene-Yeboah M, Adjei E. Breast cancer in Kumasi, Ghana. Ghana Med J 2012;46:813.
  • 29
    Adebamowo CA, Famooto A, Ogundiran TO, et al. Immunohistochemical and molecular subtypes of breast cancer in Nigeria. Breast Cancer Res Treat 2008;110:1838.
  • 30
    Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 2012;62:22041.
  • 31
    Mbonde MP, Amir H, Akslen LA, et al. Expression of oestrogen and progesterone receptors, Ki67, p53 and BCL-2 proteins, cathepsin D, urokinase plasminogen activator and urokinase plasminogen activator-receptors in carcinomas of the female breast in an African Population. East Afr Med J 2001;78:360-5.
  • 32
    Mousa SM, Seifeldin IA, Hablas A, et al. Patterns of seeking medical care among Egyptian breast cancer patients: relationship to late-stage presentation. Breast 2011;20:55561.
  • 33
    Huo D, Ikpatt F, Khramtsov A, et al. Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. J Clin Oncol 2009;27:451521.
  • 34
    Thorat MA, Rangole A, Nadkarni MS, et al. Revision surgery for breast cancer: single-institution experience. Cancer 2008;113:234752.
  • 35
    Maskarinec G, Sen C, Koga K, et al. Ethnic differences in breast cancer survival: status and determinants. Womens Health (Lond Engl) 2011;7:67787.
  • 36
    Jakobsson M, Scholz SW, Scheet P, et al. Genotype, haplotype and copy-number variation in worldwide human populations. Nature 2008;451:9981003.
  • 37
    Akarolo-Anthony SN, Ogundiran TO, Adebamowo CA. Emerging breast cancer epidemic: evidence from Africa. Breast Cancer Res 2010;12 (Suppl 4):S8.
  • 38
    Dye TD, Bogale S, Hobden C, et al. Complex care systems in developing countries: breast cancer patient navigation in Ethiopia. Cancer 2010;116:57785.
  • 39
    Sankaranarayanan R, Sauvaget C, Ramadas K, et al. Clinical trials of cancer screening in the developing world and their impact on cancer healthcare. Ann Oncol 2011;22 (Suppl 7):vii20-vii28.